7Kiyanagi T, Miyazaki T, Kume A, et al. Decrease in CETP activity by fenofibrate may increase LDL particle size measured by HPLC method in patients with coronary artery disease [J]. Atherosclerosis, 2006, 7 (3 Suppl):559.
8Rizzo M, Berneis K. The clinical significance of the size of love density-lipoproteins and the modulation of subclasses by fibrates [J]. Curr Med Res Opin, 2007, 23 (5) :1103-1111.
9Superko RH, Berneis KK, Williams P, et al. Gemfibrozil re- duces small low-density lipoprotein more in normolipemic sub- jects classified as low density lipoprotein pattern B compared with pattern A[J]. Am J Cardiol, 2005, 96 (9): 1266-1272.
10Rizzo M, Rini GB,Berneis K. Effects of statins, fibrates, rosu- vastatln and ezetimibe beyond cholesterol: the modulation of LDL size and subclasses in high-risk patients [J]. Adv Ther, 2007, 24 (3): 575-582.
